Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07312604) titled 'A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Abeer Mohamed Abdelaziz Elkholy
Condition:
Tinea Corporis
Tinea Cruris
Intervention:
Biological: Intra-Lesional MMR Immunotherapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: December 9, 2025
Target Sample Size: 50
Countries of Recruit...